Lirum Therapeutics, Inc. (“Lirum”), an innovative clinical-stage biopharmaceutical company focused on the treatment of debilitating diseases, announced today that new LX-101 ...
WILMETTE, Ill., April 19, 2026 (GLOBE NEWSWIRE) -- (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company developing innovative treatments for patients with unmet ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果